Phage treatment plus standard care for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Infections, Skin clinical trials.
This trial compares standard treatment with an added “phage” therapy (virus-like treatment that targets bacteria) versus a placebo for diabetic foot ulcers infected with Staphylococcus aureus. It aims to see if phage therapy can better clear the infection and help the wound heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (at least 18) with type 1 or type 2 diabetes.
- You have a foot wound below the ankle that has been getting worse for more than 2 weeks.
- The wound is large enough (at least 0.5 cm²) and is a nerve-related foot ulcer.
- You’re being seen in a hospital/clinic that runs the study.
- Your ulcer infection involves Staphylococcus aureus (MRSA or MSSA), and the bacteria are tested to see if phage can work against them.
- There is no osteomyelitis (bone infection) and no major blood-flow blockage in the affected foot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This trial studies an approach to treat bacteria living in a diabetic foot ulcer and help prevent the ulcer from coming back. You may be able to join if you have an open diabetic foot ulcer and good blood flow to the wound.
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
This study tests a treatment using viruses (phages) that kill staph bacteria in people with an infected hip or knee replacement. The treatment is given after a surgery to clean the joint, and the goal is to see if it's safe and effective.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
This trial tests a new treatment for foot ulcers caused by poor blood flow and diabetes. It compares the new treatment to a placebo (an inactive substance) to see if it helps ulcers heal better.
Hear when a new Diabetic Foot trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.